Prions and their partners in crime
The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Abstract
Prions, the infectious agents of transmissible spongiform encephalopathies (TSEs), have defied full characterization for decades. The dogma has been that prions lack nucleic acids and are composed of a pathological, self-inducing form of the host's prion protein (PrP). Recent progress in propagating TSE infectivity in cell-free systems has effectively ruled out the involvement of foreign nucleic acids. However, host-derived nucleic acids or other non-PrP molecules seem to be crucial. Interactions between TSE-associated PrP and its normal counterpart are also pathologically important, so the physiological functions of normal PrP and how they might be corrupted by TSE infections have been the subject of recent research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PrPSc levels are in many cases poorly correlated with prion disease progression, suggesting that it is necessary but not sufficient; ‘something else’ is required”
Citations
Cites
Caughey, B., & Lansbury, P. T. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081142 · Cited by 1,650
Self-citationThe cellular prion protein binds copper in vivo
Brown, D. R., Qin, K., Herms, J. W., Madlung, A., Manson, J., Strome, R., Fraser, P. E., Kruck, T., von Bohlen, A., Schulz-Schaeffer, W., et al. (1997) · Nature · doi:10.1038/37783 · Cited by 1,273
Legname, G., Baskakov, I. V., Nguyen, H.-O. B., Riesner, D., Cohen, F. E., DeArmond, S. J., & Prusiner, S. B. (2004) · Science · doi:10.1126/science.1100195 · Cited by 1,021 · cited 1×
“One team showed that synthetic truncated PrP fibril preparations can induce TSE disease when inoculated into transgenic mice that vastly overexpress the same truncated PrP construc”
BackgroundCells release prions in association with exosomes
Fevrier, B., Vilette, D., Archer, F., Loew, D., Faigle, W., Vidal, M., Laude, H., & Raposo, G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308413101 · Cited by 997
S-Nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration
Uehara, T., Nakamura, T., Yao, D., Shi, Z.-Q., Gu, Z., Ma, Y., Masliah, E., Nomura, Y., & Lipton, S. A. (2006) · Nature · doi:10.1038/nature04782 · Cited by 906
The most infectious prion protein particles
Silveira, J. R., Raymond, G. J., Hughson, A. G., Race, R. E., Sim, V. L., Hayes, S. F., & Caughey, B. (2005) · Nature · doi:10.1038/nature03989 · Cited by 899 · cited 2×
“To better characterize the minimal infectious unit and the most infectious particles per unit protein, Silveira et al.(17) developed new methods for gently disaggregating scrapie prion aggregates in detergent and separating them by size using flow field-flow fractionation.”
MethodSelf-citationNormal host prion protein necessary for scrapie-induced neurotoxicity
Brandner, S., Isenmann, S., Raeber, A., Fischer, M., Sailer, A., Kobayashi, Y., Marino, S., Weissmann, C., & Aguzzi, A. (1996) · Nature · doi:10.1038/379339a0 · Cited by 810 · cited 1×
“This is consistent with earlier studies that described reduced PrPres-induced neuropathology in brain tissue that lacks PrP C (ref”
ResultPrion protein is necessary for normal synaptic function
Collinge, J., Whittington, M. A., Sidle, K. C. L., Smith, C. J., Palmer, M. S., Clarke, A. R., & Jefferys, J. G. R. (1994) · Nature · doi:10.1038/370295a0 · Cited by 799
In Vitro Generation of Infectious Scrapie Prions
Castilla, J., Saá, P., Hetz, C., & Soto, C. (2005) · Cell · doi:10.1016/j.cell.2005.02.011 · Cited by 790 · cited 1×
“have demonstrated the cell-free propagation of PrPres and accompanying robust TSE infectivity, but many molecules besides PrP were also presen”
BackgroundDepleting Neuronal PrP in Prion Infection Prevents Disease and Reverses Spongiosis
Mallucci, G., Dickinson, A., Linehan, J., Klöhn, P.-C., Brandner, S., & Collinge, J. (2003) · Science · doi:10.1126/science.1090187 · Cited by 770
Shyng, S.-L., Lehmann, S., Moulder, K. L., & Harris, D. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.30221 · Cited by 704
Altered circadian activity rhythms and sleep in mice devoid of prion protein
Tobler, I., Gaus, S. E., Deboer, T., Achermann, P., Fischer, M., Rülicke, T., Moser, M., Oesch, B., McBride, P. A., & Manson, J. C. (1996) · Nature · doi:10.1038/380639a0 · Cited by 663
Anchorless Prion Protein Results in Infectious Amyloid Disease Without Clinical Scrapie
Chesebro, B., Trifilo, M., Race, R., Meade-White, K., Teng, C., LaCasse, R., Raymond, L., Favara, C., Baron, G., Priola, S., et al. (2005) · Science · doi:10.1126/science.1110837 · Cited by 652 · cited 1×
“However, they do not seem to be essential, because both PrPres and TSE infectivity can be amplified in transgenic mice expressing only 'anchorless' PrP C , which lacks a GPI anchor and is greatly underglycosylate”
BackgroundSelf-citationCaughey, B., & Raymond, G. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55257-1 · Cited by 637
Self-citationRole of microglia and host prion protein in neurotoxicity of a prion protein fragment
Brown, D. R., Schmidt, B., & Kretzschmar, H. A. (1996) · Nature · doi:10.1038/380345a0 · Cited by 502
Evidence for synthesis of scrapie prion proteins in the endocytic pathway.
Borchelt, D. R., Taraboulos, A., & Prusiner, S. B. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41985-0 · Cited by 498
Neurotoxicity and Neurodegeneration When PrP Accumulates in the Cytosol
Ma, J., Wollmann, R., & Lindquist, S. (2002) · Science · doi:10.1126/science.1073725 · Cited by 487 · cited 1×
“, the retrograde transport of PrP C from the endoplasmic reticulum to the cytoplasm as a key neurotoxic mechanis”
BackgroundCaughey, B., Raymond, G. J., Ernst, D., & Race, R. E. (1991) · Journal of Virology · doi:10.1128/jvi.65.12.6597-6603.1991 · Cited by 420
Self-citationSantuccione, A., Sytnyk, V., Leshchyns'ka, I., & Schachner, M. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200409127 · Cited by 419 · cited 1×
“Particularly notable is the abundant evidence that PrP C has a role in neuronal neurit”
BackgroundCross-Linking Cellular Prion Protein Triggers Neuronal Apoptosis in Vivo
Solforosi, L., Criado, J. R., McGavern, D. B., Wirz, S., Sánchez-Alavez, M., Sugama, S., DeGiorgio, L. A., Volpe, B. T., Wiseman, E., Abalos, G., et al. (2004) · Science · doi:10.1126/science.1094273 · Cited by 366
Cellular isoform of the scrapie agent protein participates in lymphocyte activation
Cashman, N. R., Loertscher, R., Nalbantoglu, J., Shaw, I., Kascsak, R. J., Bolton, D. C., & Bendheim, P. E. (1990) · Cell · doi:10.1016/0092-8674(90)90225-4 · Cited by 337
Cellular prion protein binds laminin and mediates neuritogenesis
Graner, E., Mercadante, A. F., Zanata, S. M., Forlenza, O. V., Cabral, A. L. B., Veiga, S. S., Juliano, M. A., Roesler, R., Walz, R., Minetti, A., et al. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00334-4 · Cited by 330
A 'unified theory' of prion propagation
Weissmann, C. (1991) · Nature · doi:10.1038/352679a0 · Cited by 305
Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor
Hundt, C. (2001) · The EMBO Journal · doi:10.1093/emboj/20.21.5876 · Cited by 291
Lopes, M. H., Hajj, G. N. M., Muras, A. G., Mancini, G. L., Castro, R. M. P. S., Ribeiro, K. C. B., Brentani, R. R., Linden, R., & Martins, V. R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2313-05.2005 · Cited by 286 · cited 1×
“Particularly notable is the abundant evidence that PrP C has a role in neuronal neurit”
BackgroundHsiao, K. K., Groth, D., Scott, M., Yang, S. L., Serban, H., Rapp, D., Foster, D., Torchia, M., Dearmond, S. J., & Prusiner, S. B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9126 · Cited by 282 · cited 1×
“Moreover, crucial work to demonstrate that the transgenic assay mice were not already making prions spontaneously, as has been shown with transgenic mice overexpressing a different mutant PrP transgen”
BackgroundSteele, A. D., Emsley, J. G., Özdinler, P. H., Lindquist, S., & Macklis, J. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511290103 · Cited by 270
Baron, G. S. (2002) · The EMBO Journal · doi:10.1093/emboj/21.5.1031 · Cited by 261
Self-citationZhang, C. C., Steele, A. D., Lindquist, S., & Lodish, H. F. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510577103 · Cited by 251
Caughey, B., Brown, K., Raymond, G. J., Katzenstein, G. E., & Thresher, W. (1994) · Journal of Virology · doi:10.1128/jvi.68.4.2135-2141.1994 · Cited by 237
Self-citationWong, C. '. (2001) · The EMBO Journal · doi:10.1093/emboj/20.3.377 · Cited by 235
Self-citationDoh-ura, K., Ishikawa, K., Murakami-Kubo, I., Sasaki, K., Mohri, S., Race, R., & Iwaki, T. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.4999-5006.2004 · Cited by 228
Drisaldi, B., Stewart, R. S., Adles, C., Stewart, L. R., Quaglio, E., Biasini, E., Fioriti, L., Chiesa, R., & Harris, D. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213247200 · Cited by 227 · cited 1×
“, the retrograde transport of PrP C from the endoplasmic reticulum to the cytoplasm as a key neurotoxic mechanis”
BackgroundLledo, P. M., Tremblay, P., DeArmond, S. J., Prusiner, S. B., & Nicoll, R. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2403 · Cited by 223
Cellular prion protein function in copper homeostasis and redox signalling at the synapse
Vassallo, N., & Herms, J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01882.x · Cited by 222
Raeber, A. J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.20.6057 · Cited by 210 · cited 1×
“However, this does not always seem to be the case, because TSE disease can occur in transgenic mice that express PrP C only in astrocyte”
BackgroundSchneider, B., Mutel, V., Pietri, M., Ermonval, M., Mouillet-Richard, S., & Kellermann, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235648100 · Cited by 205
Identification of the Heparan Sulfate Binding Sites in the Cellular Prion Protein
Warner, R. G., Hundt, C., Weiss, S., & Turnbull, J. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110406200 · Cited by 205
The Disulfide Isomerase Grp58 Is a Protective Factor against Prion Neurotoxicity
Hetz, C., Russelakis-Carneiro, M., Wälchli, S., Carboni, S., Vial-Knecht, E., Maundrell, K., Castilla, J., & Soto, C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4090-04.2005 · Cited by 197 · cited 1×
“One possibility is that PrPres is directly toxic to neuron”
BackgroundStrain-specified characteristics of mouse synthetic prions
Legname, G., Nguyen, H.-O. B., Baskakov, I. V., Cohen, F. E., DeArmond, S. J., & Prusiner, S. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409079102 · Cited by 196 · cited 1×
“One team showed that synthetic truncated PrP fibril preparations can induce TSE disease when inoculated into transgenic mice that vastly overexpress the same truncated PrP construc”
BackgroundDeleault, N. R., Geoghegan, J. C., Nishina, K., Kascsak, R., Williamson, R. A., & Supattapone, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503973200 · Cited by 196 · cited 1×
“have shown that similar PrPres amplification can be supported using only PrPres, PrP C purified from brain samples, and polyanionic accessory molecules such as nucleic acids and heparan sulphate proteoglycan (HSPG”
BackgroundBrain Copper Content and Cuproenzyme Activity Do Not Vary with Prion Protein Expression Level
Waggoner, D. J., Drisaldi, B., Bartnikas, T. B., Casareno, R. L. B., Prohaska, J. R., Gitlin, J. D., & Harris, D. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7455 · Cited by 192 · cited 1×
“However, some of these phenotypes have been dispute”
BackgroundChen, S., Mangé, A., Dong, L., Lehmann, S., & Schachner, M. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(02)00014-3 · Cited by 189
Criado, J. R., Sánchez-Alavez, M., Conti, B., Giacchino, J. L., Wills, D. N., Henriksen, S. J., Race, R., Manson, J. C., Chesebro, B., & Oldstone, M. B. A. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.01.001 · Cited by 189
Copper Chelation Delays the Onset of Prion Disease
Sigurdsson, E. M., Brown, D. R., Alim, M. A., Scholtzova, H., Carp, R., Meeker, H. C., Prelli, F., Frangione, B., & Wisniewski, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300303200 · Cited by 188 · cited 1×
“Paradoxically, copper-chelation therapy also delayed the onset of scrapie in mic”
BackgroundProtease-resistant prion protein produced in vitro lacks detectable infectivity.
Hill, A. F., Antoniou, M., & Collinge, J. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-1-11 · Cited by 185 · cited 1×
“However, the yield of these simple conversion reactions was limited, and the newly made PrPres was not proved to be infectious (ref”
BackgroundKanaani, J., Prusiner, S. B., Diacovo, J., Baekkeskov, S., & Legname, G. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03469.x · Cited by 184
Heparan Sulfate Is a Cellular Receptor for Purified Infectious Prions
Horonchik, L., Tzaban, S., Ben-Zaken, O., Yedidia, Y., Rouvinski, A., Papy-Garcia, D., Barritault, D., Vlodavsky, I., & Taraboulos, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500122200 · Cited by 181 · cited 1×
“( Box 2 ), co-localize with PrPres deposits in vivo , and serve as PrPres receptors on the surface of cells in vitro”
BackgroundShyng, S.-L., Moulder, K. L., Lesko, A., & Harris, D. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14793 · Cited by 180
The highways and byways of prion protein trafficking
CAMPANA, V, SARNATARO, D., & ZURZOLO, C. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.12.002 · Cited by 179
Quaglio, E., Chiesa, R., & Harris, D. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009666200 · Cited by 173 · cited 1×
“Copper Copper induces the conversion of PrP C to protease-resistant, detergent-insoluble aggregate”
BackgroundCopper(II) Inhibits in Vitro Conversion of Prion Protein into Amyloid Fibrils
Bocharova, O. V., Breydo, L., Salnikov, V. V., & Baskakov, I. V. (2005) · Biochemistry · doi:10.1021/bi050251q · Cited by 171 · cited 1×
“Similarly, spontaneous polymerization of recombinant PrP (rPrP) into amyloid fibrils was inhibited by copper treatment, which apparently stabilized non-amyloid, α-helical, proteinase-K-resistant rPrP aggregate”
BackgroundNew Insights into Prion Structure and Toxicity
Harris, D. A., & True, H. L. (2006) · Neuron · doi:10.1016/j.neuron.2006.04.020 · Cited by 163
Cellular Prion Protein Promotes Brucella Infection into Macrophages
Watarai, M., Kim, S., Erdenebaatar, J., Makino, S., Horiuchi, M., Shirahata, T., Sakaguchi, S., & Katamine, S. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021980 · Cited by 162 · cited 1×
“, and the use of PrP C as a receptor by Brucella species of bacteri”
BackgroundPrion Diseases: What Is the Neurotoxic Molecule?
Chiesa, R., & Harris, D. A. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0433 · Cited by 160 · cited 1×
“Studies of transgenic mice expressing various mutant PrP C molecules have revealed that perturbations in the structure of PrP C , its expression levels and functions can cause neurological disease, even in the absence of TSE infection (reviewed in ref”
BackgroundUptake and Neuritic Transport of Scrapie Prion Protein Coincident with Infection of Neuronal Cells
Magalhães, A. C., Baron, G. S., Lee, K. S., Steele-Mortimer, O., Dorward, D., Prado, M. A. M., & Caughey, B. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0653-05.2005 · Cited by 158
Self-citationCellular prion protein neuroprotective function: implications in prion diseases
Roucou, X., & LeBlanc, A. C. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0605-5 · Cited by 158
Leucht, C., Simoneau, S., Rey, C., Vana, K., Rieger, R., Lasmézas, C. I., & Weiss, S. (2003) · EMBO reports · doi:10.1038/sj.embor.embor768 · Cited by 157
Taylor, D. R., Watt, N. T., Perera, W. S. S., & Hooper, N. M. (2005) · Journal of Cell Science · doi:10.1242/jcs.02627 · Cited by 154
Immunodetection of disease‐associated mutant PrP, which accelerates disease in GSS transgenic mice
Nazor, K. E., Kühn, F., Seward, T. S., Green, M. A., Zwald, D., Pürro, M., Schmid, J., Biffiger, K., Power, A. M., Oesch, B., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600717 · Cited by 150 · cited 2×
“To further complicate matters, Nazor et al.(6) found that in similar transgenic mice inoculation of mutant-PrP aggregates from one transgenic mouse into others promotes the accumulation of pre-existing pathological forms of mutant PrP produced as a result of transgene overexpression.”
BackgroundKristiansen, M., Messenger, M. J., Klöhn, P.-C., Brandner, S., Wadsworth, J. D. F., Collinge, J., & Tabrizi, S. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506600200 · Cited by 148 · cited 1×
“One possibility is that PrPres is directly toxic to neuron”
BackgroundPrion Protein Expression in Human Leukocyte Differentiation
Dodelet, V. C., & Cashman, N. R. (1998) · Blood · doi:10.1182/blood.v91.5.1556 · Cited by 146
Cellular Heparan Sulfate Participates in the Metabolism of Prions
Ben-Zaken, O., Tzaban, S., Tal, Y., Horonchik, L., Esko, J. D., Vlodavsky, I., & Taraboulos, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301152200 · Cited by 142 · cited 1×
“In addition to participating in PrPres biosynthesi”
Cellular prion protein: on the road for functions
Martins, V. R., Linden, R., Prado, M. A. M., Walz, R., Sakamoto, A. C., Izquierdo, I., & Brentani, R. R. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02291-3 · Cited by 137
Reversibility of Scrapie Inactivation Is Enhanced by Copper
McKenzie, D., Bartz, J., Mirwald, J., Olander, D., Marsh, R., & Aiken, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25545 · Cited by 134 · cited 1×
“Copper loading can also enhance the protease resistance and recovery of infectivity from partly denatured PrPres preparation”
BackgroundPrion diseases — close to effective therapy?
Cashman, N. R., & Caughey, B. W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1525 · Cited by 134
Self-citationBovine Prion Is Endocytosed by Human Enterocytes via the 37 kDa/67 kDa Laminin Receptor
Morel, É., Andrieu, T., Casagrande, F., Gauczynski, S., Weiss, S. F. T., Grassi, J., Rousset, M., Dormont, D., & Chambaz, J. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61192-3 · Cited by 131 · cited 1×
“More recent studies have reported evidence for direct interactions between LRP/LR and PrPres in mediating binding of exogenous PrPres to enterocyte”
BackgroundShyu, W.-C., Lin, S.-Z., Chiang, M.-F., Ding, D.-C., Li, K.-W., Chen, S.-F., Yang, H.-I., & Li, H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1115-05.2005 · Cited by 127
The cellular prion protein modulates phagocytosis and inflammatory response
de Almeida, C. J. G., Chiarini, L. B., da Silva, J. P., e Silva, P. M. R., Martins, M. A., & Linden, R. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1103531 · Cited by 116
Copper binding to PrPC may inhibit prion disease propagation
Hijazi, N., Shaked, Y., Rosenmann, H., Ben‐Hur, T., & Gabizon, R. (2003) · Brain Research · doi:10.1016/j.brainres.2003.09.014 · Cited by 112 · cited 1×
“Copper treatment inhibits PrPres formation in cell-culture models of prion infection and can delay the onset of disease in scrapie-infected hamster”
BackgroundScrapie‐specific neuronal lesions are independent of neuronal PrP expression
Jeffrey, M., Goodsir, C. M., Race, R. E., & Chesebro, B. (2004) · Annals of Neurology · doi:10.1002/ana.20093 · Cited by 105 · cited 1×
“However, this does not always seem to be the case, because TSE disease can occur in transgenic mice that express PrP C only in astrocyte”
BackgroundPotent Antiscrapie Activities of Degenerate Phosphorothioate Oligonucleotides
Kocisko, D. A., Vaillant, A., Lee, K. S., Arnold, K. M., Bertholet, N., Race, R., Olsen, E. A., Juteau, J., & Caughey, B. W. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.1034-1044.2006 · Cited by 105 · cited 1×
“In this context, the binding of PrP C by cell-surface GAGs might keep PrP C molecules occupied until preferred ligands appear, because GAGs can compete for the same sites on PrP C (ref”
BackgroundSelf-citationRational targeting for prion therapeutics
Mallucci, G. R., & Collinge, J. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1584 · Cited by 103 · cited 1×
“Because transgenic PrP 0/0 mice, which either lack PrP altogether or have their PrP C expression turned off in adulthood, do not exhibit the symptoms of TSE diseas”
BackgroundGonzález‐Iglesias, R., Pajares, M. A., Ocal, C., Espinosa, J. C., Oesch, B., & Gasset, M. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00341-8 · Cited by 95
The prion protein and neuronal zinc homeostasis
Watt, N. T., & Hooper, N. M. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00166-x · Cited by 93
Is loss of function of the prion protein the cause of prion disorders?
Hetz, C. A., Maundrell, K., & Soto, C. A. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00069-8 · Cited by 86 · cited 1×
“Because transgenic PrP 0/0 mice, which either lack PrP altogether or have their PrP C expression turned off in adulthood, do not exhibit the symptoms of TSE diseas”
BackgroundPrPSc Incorporation to Cells Requires Endogenous Glycosaminoglycan Expression
Hijazi, N., Kariv-Inbal, Z., Gasset, M., & Gabizon, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411314200 · Cited by 85
Raymond, G. J., Olsen, E. A., Lee, K. S., Raymond, L. D., Bryant, P. K., Baron, G. S., Caughey, W. S., Kocisko, D. A., McHolland, L. E., Favara, C., et al. (2005) · Journal of Virology · doi:10.1128/jvi.80.2.596-604.2006 · Cited by 75
Self-citationAltered behavioural response to acute stress in mice lacking cellular prion protein
Nico, P. B. C., de Paris, F., Vinadé, E. R., Amaral, O. B., Rockenbach, I. C., Soares, B. L., Guarnieri, R., Wichert‐Ana, L., Calvo, F., Walz, R., et al. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.02.003 · Cited by 74
Caughey, B. W., Caughey, W. S., Kocisko, D. A., Lee, K. S., Silveira, J. R., & Morrey, J. D. (2006) · Accounts of Chemical Research · doi:10.1021/ar050068p · Cited by 68
Self-citationShaked, G. M., Meiner, Z., Avraham, I., Taraboulos, A., & Gabizon, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007815200 · Cited by 62
Copper (II) ions potently inhibit purified PrPres amplification
Orem, N. R., Geoghegan, J. C., Deleault, N. R., Kascsak, R. J., & Supattapone, S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03650.x · Cited by 55 · cited 1×
“Copper inhibited PrPres amplification in reactions using purified, brain-derived PrP C as a substrate and PrPres as a see”
MethodKiachopoulos, S., Heske, J., Tatzelt, J., & Winklhofer, K. F. (2004) · Traffic · doi:10.1111/j.1398-9219.2004.00185.x · Cited by 50 · cited 1×
“Copper treatment inhibits PrPres formation in cell-culture models of prion infection and can delay the onset of disease in scrapie-infected hamster”
BackgroundMarella, M., Gaggioli, C., Batoz, M., Deckert, M., Tartare‐Deckert, S., & Chabry, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410966200 · Cited by 50
Neurotoxicity of prion peptide 106‐126 not confirmed
Kunz, B., Sandmeier, E., & Christen, P. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01123-0 · Cited by 48
Nishina, K., Jenks, S., & Supattapone, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406548200 · Cited by 47
A Porphyrin Increases Survival Time of Mice after Intracerebral Prion Infection
Kocisko, D. A., Caughey, W. S., Race, R., Roper, G., Caughey, B. W., & Morrey, J. D. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.759-761.2006 · Cited by 47
Self-citationCellular prion protein acquires resistance to proteolytic degradation following copper ion binding
Kuczius, T., Buschmann, A., Zhang, W., Karch, H., Becker, K., Peters, G., & Groschup, M. H. (2004) · Biological Chemistry · doi:10.1515/bc.2004.090 · Cited by 44 · cited 1×
“Copper Copper induces the conversion of PrP C to protease-resistant, detergent-insoluble aggregate”
BackgroundYin, S., Yu, S., Li, C., Wong, P., Chang, B., Xiao, F., Kang, S. C., Yan, H., Xiao, G., Grassi, J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511819200 · Cited by 42
Jouvin‐Marche, E., Attuil-Audenis, V., Aude‐Garcia, C., Rachidi, W., Zabel, M. D., Podevin-Dimster, V., Siret, C., Huber, C., Martinic, M. M. A., Riondel, J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3490 · Cited by 41
The Hypothesis of the Catalytic Action of Nucleic Acid on the Conversion of Prion Protein
Cordeiro, Y., & Silva, J. L. (2005) · Protein and Peptide Letters · doi:10.2174/0929866053587138 · Cited by 36
Vana, K., & Weiss, S. F. T. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.02.011 · Cited by 35
Fontès, P., Alvarez‐Martinez, M., Gross, A., Carnaud, C., Köhler, S., & Liautard, J. (2005) · Infection and Immunity · doi:10.1128/iai.73.10.6229-6236.2005 · Cited by 32 · cited 1×
“, and the use of PrP C as a receptor by Brucella species of bacteri”
BackgroundPrion Protein and the Molecular Features of Transmissible Spongiform Encephalopathy Agents
Silveira, J. R., Caughey, B. W., & Baron, G. S. (2004) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-08441-0_1 · Cited by 24
Self-citationAxonal transport of the cellular prion protein is increased during axon regeneration
Moya, K. L., Hässig, R., Breen, K. C., Volland, H., & Giamberardino, L. D. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02940.x · Cited by 22
Leucht, C., Vana, K., Renner‐Müller, I., Dormont, D., Lasmézas, C. I., Wolf, E., & Weiss, S. F. T. (2004) · Transgenic Research · doi:10.1023/b:trag.0000017177.35197.89 · Cited by 19 · cited 1×
“Development of LRP/LR knock-down transgenic mice will help to evaluate the role of this protein in prion pathogenesi”
Background
Research works printed but not linked: 1
- Ben-Zaken, O. et al. Cellular heparan sulfate participates in the metabolism of prions. J. Biol. Chem. 278, 40041–40049 (2003). · DOI · Paper page
Cited by
The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization
Hamley, I. W. (2012) · Chemical Reviews · doi:10.1021/cr3000994 · Cited by 882
Generating a Prion with Bacterially Expressed Recombinant Prion Protein
Wang, F., Wang, X., Yuan, C.-G., & Ma, J. (2010) · Science · doi:10.1126/science.1183748 · Cited by 661
Hamley, I. W. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200700861 · Cited by 618
Physiology of the prion protein
Linden, R., Martins, V. R., Prado, M. A. M., Cammarota, M., Izquierdo, I., & Brentani, R. R. (2008) · Physiological Reviews · doi:10.1152/physrev.00007.2007 · Cited by 617
The two faces of protein misfolding: gain‐ and loss‐of‐function in neurodegenerative diseases
Winklhofer, K. F., Tatzelt, J., & Haass, C. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601930 · Cited by 401
“Even if infectivity is entirely deciphered in the conformation of PrPSc, it seems plausible that auxiliary components can significantly modulate various aspects in the pathogenesis of prion dis- eases (for a review, see Caughey and Baron, 2006).”
Background
Metadata
- Authors
- Caughey, B., & Baron, G. S.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Caughey, Byron
- Baron, Gerald S.
- Venue
- Nature
- Published
- 2006-10
- Volume
- 443
- Issue
- 7113
- Pages
- 803-810
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2057579163
- Cited by
- 295
- References
- 96
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3 · 2023: 1 · 2022: 4 · 2021: 3 · 2020: 2 · 2019: 3 · 2018: 5 · 2017: 8 · 2016: 10 · 2015: 11 · 2014: 11 · 2013: 14 · 2012: 19
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- prions, prion disease, prion protein, prion pathogenesis
- MeSH terms
- Animals, Copper, Humans, Ligands, Prions, Prion Diseases, Glycosylphosphatidylinositols
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.